[Efficacy of Mexidol in patients with type 2 diabetes mellitus with neurological complications].

Published in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2022)

Mexidol administration for the period 75 days may serve as important therapeutic supplementation and considered as adjunctive therapy in the treatment of patients with DM.

Keyphrases

metabolic syndrome
combination therapy
adipose tissue
mesenchymal stem cells
skeletal muscle